Septerna Inc. Common Stoc... (SEPN)
16.99
0.03 (0.18%)
At close: Jan 15, 2025, 3:59 PM
17.00
0.06%
After-hours Jan 15, 2025, 04:00 PM EST
Company Description
No Company description available at the moment.
Septerna Inc. Common Stock
| Country | n/a |
| IPO Date | n/a |
| Industry | n/a |
| Sector | n/a |
| Employees | 68 |
| CEO | Dr. Jeffrey T. Finer M.D., Ph.D. |
Contact Details
Address: No Address available No city data available, | |
| Website | n/a |
Stock Details
| Ticker Symbol | n/a |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | n/a |
| CIK Code | n/a |
| CUSIP Number | 81734D104 |
| ISIN Number | US81734D1046 |
| Employer ID | - |
| SIC Code | n/a |
Key Executives
| Name | Position |
|---|---|
| Dr. Jeffrey T. Finer M.D., Ph.D. | Co-Founder, Chief Executive Officer, President & Director |
| Elizabeth P. Bhatt M.B.A., M.S. | Chief Operating Officer |
| Ran Xiao C.F.A., M.B.A. | Interim Chief Financial Officer and Vice President of Finance & Business Operations |
| Samira Shaikhly | Chief People Officer |
| Dr. Arthur Christopoulos BPHARM, Ph.D. | Co-Founder and Member of Cross-Functional Scientific & Drug Discovery Advisory Board |
| Dr. Daniel Long DPHIL | Senior Vice President of Drug Discovery |
| Dr. Patrick Sexton Ph.D. | Co-Founder and Member of Cross-Functional Scientific & Drug Discovery Advisory Board |
| Dr. Robert J. Lefkowitz M.D. | Co-Founder and Member of Cross-Functional Scientific & Drug Discovery Advisory Board |
| Richard Hansen Ph.D. | Vice President of Technology |
| Uwe Klein Ph.D. | Senior Vice President of Biological Sciences |